Skip to content

Impact of Xenazine(Tetrabenazine)on Gait and Functional Activity in Individuals With Huntington's Disease

Impact of Xenazine(Tetrabenazine)on Gait and Functional Activity in Individuals With Huntington's Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01451463
Enrollment
11
Registered
2011-10-13
Start date
2010-04-30
Completion date
2013-04-30
Last updated
2017-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Huntington's Disease

Keywords

Huntington's Disease, Chorea, Gait, Balance

Brief summary

In individuals with Huntington's disease (HD), chorea may contribute to balance problems and difficulties with walking, sit to stand transfers and stair climbing that in turn may contribute to high fall rates. Xenazine (tetrabenazine) is a monoamine-depleting drug that is commonly used to reduce chorea. The purpose of this study is to compare: 1) spatial and temporal gait measures, 2) performance on functional mobility measures, and 3) amount of daily walking activity before and after administration of Xenazine in individuals with HD. It is hypothesized that the use of Xenazine to decrease chorea will improve functions of 1) gait, 2) sit-to-stand transfers 3) stair climbing and 4) overall daily physical activity and function.

Detailed description

Individuals with HD who are ambulatory and are either already taking Xenazine or have been newly prescribed the medication will be recruited for this prospective open-label study. A variety of motor assessments will be preformed while subject are taking Xenazine or after a period off of the medications. These tests include: Unified Huntington's Disease Rating Scale (UHDRS) motor section, GAITRite forward walking, Tinetti Mobility Test, Timed Sit-to-Stand Test, Timed Stair Climb Test, Rhomberg test. A subset of subjects will wear an activity monitoring device on the wrist of the non-dominant hand for 5 consecutive days and nights.

Interventions

None listed

Sponsors

Lundbeck LLC
CollaboratorINDUSTRY
Ohio State University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Huntington's Disease * Able to ambulate independently

Exclusion criteria

* Other orthopedic or neurological disorder that affects gait or balance * Pregnancy * Chorea score \<10 prior to initiation of medication. * Inability to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Tinetti Mobility Test Score>18 hours off Stable Dose of Tetrabenazine and at 2 hours after resumption of TetrabenazineThe Tinetti Mobility Test is a clinical test used to assess balance and gait. The Balance sub-score ranges from 0-16 (with 16 reflecting better balance) while the Gait sub-score ranges from 0-12 (with 12 reflecting better gait parameters). The Total Tinetti Mobility Test Score (TMT) is a sum of the two sub-scores with a maximum score of 28. The higher the score the better the gait and balance performance. A comparison of scores off regular stable dose of tetrabenazine for \>18 hours with the performance two hours after resuming tetrabenazine was made.

Secondary

MeasureTime frameDescription
Five Times Sit to Stand Test>18 hours off Stable Dose of Tetrabenazine and at 2 hours after resumption of TetrabenazineSubjects are asked to sit in a chair with their arms across their chests and asked to stand and sit five times in a row. The time it takes to complete 5 sit to stand cycles is timed with a stop watch. Comparison is made when off stable dose of tetrabenazine for \>18 hours to performance 2 hours after resumption of tetrabenazine. Lower time scores are associated with better balance.

Other

MeasureTime frameDescription
Six Condition Romberg Test>18 hours off Stable Dose of Tetrabenazine and at 2 hours after resumption of TetrabenazineThe Six Condition Romberg Test is used assess static balance. Subjects are tested standing with their arms crossed over their chests and are assessed for 30 seconds in the following 6 conditions: 1) feet together, 2) feet together eyes closed, 3) feet aligned in tandem heel-to-toe position eyes open, 4) feet aligned in tandem heel-to-toe position eyes closed, 5) standing in tandem position while counting backwards by 3's from 100 with eyes open, 6) standing in tandem position while counting backwards by 3's from 100 with eyes closed. Comparison of performances were made when off stable dose of tetrabenazine for \> 18 hours to performance 2 hours after resumption of tetrabenazine. If a participant could not hold a stance for the full 30 seconds, then that component of the Romberg test ended at that point with the time of that component scored in seconds; 30 seconds being the maximum score for each of the 6 tests. The total score was calculated as a sum of all of the 6 subset scores.

Countries

United States

Participant flow

Participants by arm

ArmCount
Individuals on Stable Doses of Tetrabenazine
11 Individuals on stable doses of tetrabenazine were studied while off medication and then following resumption of medication.
11
Total11

Baseline characteristics

CharacteristicIndividuals on Stable Doses of Tetrabenazine
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
1 Participants
Age, Categorical
Between 18 and 65 years
10 Participants
Age, Continuous52.2 years
STANDARD_DEVIATION 10
Region of Enrollment
United States
11 participants
Sex: Female, Male
Female
9 Participants
Sex: Female, Male
Male
2 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 11
serious
Total, serious adverse events
0 / 11

Outcome results

Primary

Tinetti Mobility Test Score

The Tinetti Mobility Test is a clinical test used to assess balance and gait. The Balance sub-score ranges from 0-16 (with 16 reflecting better balance) while the Gait sub-score ranges from 0-12 (with 12 reflecting better gait parameters). The Total Tinetti Mobility Test Score (TMT) is a sum of the two sub-scores with a maximum score of 28. The higher the score the better the gait and balance performance. A comparison of scores off regular stable dose of tetrabenazine for \>18 hours with the performance two hours after resuming tetrabenazine was made.

Time frame: >18 hours off Stable Dose of Tetrabenazine and at 2 hours after resumption of Tetrabenazine

ArmMeasureValue (MEAN)Dispersion
Individuals 2 Hours After Resuming TetrabenazineTinetti Mobility Test Score19.91 Total Tinetti Mobility Test Score (TMT)Standard Deviation 3.53
Individuals Off Their Stable Dose of Tetrabenazine for > 18 hrTinetti Mobility Test Score17.09 Total Tinetti Mobility Test Score (TMT)Standard Deviation 4.04
Secondary

Five Times Sit to Stand Test

Subjects are asked to sit in a chair with their arms across their chests and asked to stand and sit five times in a row. The time it takes to complete 5 sit to stand cycles is timed with a stop watch. Comparison is made when off stable dose of tetrabenazine for \>18 hours to performance 2 hours after resumption of tetrabenazine. Lower time scores are associated with better balance.

Time frame: >18 hours off Stable Dose of Tetrabenazine and at 2 hours after resumption of Tetrabenazine

ArmMeasureValue (MEAN)Dispersion
Individuals 2 Hours After Resuming TetrabenazineFive Times Sit to Stand Test12.61 seconds to complete 5 sit to stand cycleStandard Deviation 3
Individuals Off Their Stable Dose of Tetrabenazine for > 18 hrFive Times Sit to Stand Test15.52 seconds to complete 5 sit to stand cycleStandard Deviation 3.81
p-value: 0.009t-test, 2 sided
Other Pre-specified

Six Condition Romberg Test

The Six Condition Romberg Test is used assess static balance. Subjects are tested standing with their arms crossed over their chests and are assessed for 30 seconds in the following 6 conditions: 1) feet together, 2) feet together eyes closed, 3) feet aligned in tandem heel-to-toe position eyes open, 4) feet aligned in tandem heel-to-toe position eyes closed, 5) standing in tandem position while counting backwards by 3's from 100 with eyes open, 6) standing in tandem position while counting backwards by 3's from 100 with eyes closed. Comparison of performances were made when off stable dose of tetrabenazine for \> 18 hours to performance 2 hours after resumption of tetrabenazine. If a participant could not hold a stance for the full 30 seconds, then that component of the Romberg test ended at that point with the time of that component scored in seconds; 30 seconds being the maximum score for each of the 6 tests. The total score was calculated as a sum of all of the 6 subset scores.

Time frame: >18 hours off Stable Dose of Tetrabenazine and at 2 hours after resumption of Tetrabenazine

ArmMeasureValue (MEAN)Dispersion
Individuals 2 Hours After Resuming TetrabenazineSix Condition Romberg Test83.08 Six Condition Romberg Test scoreStandard Deviation 27.57
Individuals Off Their Stable Dose of Tetrabenazine for > 18 hrSix Condition Romberg Test73.26 Six Condition Romberg Test scoreStandard Deviation 16.29
p-value: 0.114t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026